Your doctor will decide whether you should use this medicine if you are unable to use other needed transplant medications.You should not breastfeed while using CellCept.CellCept pregnancy and breastfeeding warnings (more detail)How should I use CellCept?Take...
CellCept may interact with cholestyramine, antibiotics,acyclovir, ganciclovir, valacyclovir, or other medicines that weaken theimmune system. Tell your doctor all medications you use. CellCept During Pregnancy and Breastfeeding CellCept is not recommended for use during pregnancy because of possible harm t...
Neutropenia has been observed most frequently in the period from 31 to 180 days post-transplant in patients treated for prevention of kidney, heart and liver rejection. The development of neutropenia may be related to CELLCEPT itself, concomitant medications, viral infections, or a combination of th...
Disposal considerations Waste from residues Contaminated packaging - incinerate in qualified installation with flue gas scrubbing - observe local/national regulations regarding waste disposal - DO NOT FLUSH unused medications or POUR them down a sink or drain. If available in your area, use takeback ...
CellCept may interact with cholestyramine, antibiotics,acyclovir, ganciclovir, valacyclovir, or other medicines that weaken theimmune system. Tell your doctor all medications you use. CellCept During Pregnancy and Breastfeeding CellCept is not recommended for use during pregnancy because of possible harm ...
- State and local regulations vary and may impose additional reporting requirements. Date: 27.12.11/LS (SEISMO) Replacing edition of: 13.10.11 Page: 7/8 CELLCEPT(R) Capsules (250 mg) 16. Other information Safety-lab number Edition documentation *1 referring to: - BS-8818 - BS-9333 - ...
CellCept may interact with cholestyramine, antibiotics,acyclovir, ganciclovir, valacyclovir, or other medicines that weaken theimmune system. Tell your doctor all medications you use. CellCept During Pregnancy and Breastfeeding CellCept is not recommended for use during pregnancy because of possible harm ...
- State and local regulations vary and may impose additional reporting requirements. Date: 27.12.11/LS (SEISMO) Replacing edition of: 13.10.11 Page: 7/8 CELLCEPT(R) Capsules (250 mg) 16. Other information Safety-lab number Edition documentation *1 referring to: - BS-8818 - BS-9333 - ...